Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy

Nature

Volumn 477, Issue 7362, 2011, Pages 95-99

  Sigal, Alex ^a   Kim, Jocelyn T ^a,b   Balazs, Alejandro B ^a   Dekel, Erez ^c   Mayo, Avi ^c   Milo, Ron ^c   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; TENOFOVIR;

CYTOLOGY; DRUG RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; INFECTIOUS DISEASE; MUTATION; RISK FACTOR; STOCHASTICITY;

ANTIVIRAL THERAPY; ARTICLE; CELL SPREADING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; STOCHASTIC MODEL; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ADENINE; ANTI-RETROVIRAL AGENTS; CELL LINE; DRUG RESISTANCE, VIRAL; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL; PHOSPHONIC ACIDS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80052395837     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10347     Document Type: Article

References (30)

1. Pierson, T.,McArthur, J.&Siliciano, R. F. Reservoirs for HIV-1:mechanismsfor viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18, 665-708 (2000). (Pubitemid 30365394)
2. Jung, A. et al. Recombination:multiply infected spleen cells in HIV patients. Nature 418, 144 (2002). (Pubitemid 34773761)
3. Dixit, N. M. & Perelson, A. S. HIV dynamics with multiple infections of target cells. Proc. Natl Acad. Sci. USA 102, 8198-8203 (2005). (Pubitemid 40800066)
4. Dimitrov, D. S. et al. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67, 2182-2190 (1993). (Pubitemid 23088394)
5. Sattentau, Q. Avoiding the void: cell-to-cell spread of human viruses. Nature Rev. Microbiol. 6, 815-826 (2008).
6. Martin, N. et al. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J. Virol. 84, 3516-3527 (2010).
7. Sourisseau, M., Sol-Foulon, N., Porrot, F., Blanchet, F. & Schwartz, O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J. Virol. 81, 1000-1012 (2007). (Pubitemid 46067924)
8. Dang, Q. et al. NonrandomHIV-1 infection and double infection via direct and cellmediated pathways. Proc. Natl Acad. Sci. USA 101, 632-637 (2004). (Pubitemid 38084688)
9. Dixit, N. M. & Perelson, A. S. Multiplicity of human immunodeficiency virus infections in lymphoid tissue. J. Virol. 78, 8942-8945 (2004). (Pubitemid 39025162)
10. Del Portillo, A. et al. Multiploid inheritance of HIV-1 during cell-to-cell infection. J. Virol. 85, 7169-7176 (2011).
11. Buzó n, M. J. et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nature Med. 16, 460-465 (2010).
12. Chun, T. W. et al. Relationship between residual plasmaviremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. J. Infect. Dis. 204, 135-138 (2011).
13. Doitsh, G. et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143, 789-801 (2010).
14. Paredes, R. et al. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J. Infect. Dis. 201, 662-671 (2010).
15. Levy, D. N., Aldrovandi, G. M., Kutsch, O. & Shaw, G. M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl Acad. Sci. USA 101, 4204-4209 (2004). (Pubitemid 38405907)
16. Gratton, S., Cheynier, R., Dumaurier, M. J., Oksenhendler, E. & Wain-Hobson, S. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc. Natl Acad. Sci. USA 97, 14566-14571 (2000). (Pubitemid 32016616)
17. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998). (Pubitemid 28093515)
18. Wu, Y., Beddall, M. H. & Marsh, J. W. Rev-dependent indicator T cell line. Curr. HIV Res. 5, 394-402 (2007). (Pubitemid 47040480)
19. Chen, B. K., Gandhi, R. T. & Baltimore, D.CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70, 6044-6053 (1996). (Pubitemid 26266819)
20. Ribeiro, R. M. et al. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J. Virol. 84, 6096-6102 (2010).
21. Nowak, M. A. & May, R. M. Virus Dynamics: Mathematical Principles of Immunology and Virology (Oxford Univ. Press, 2000).
22. Mathias, A. A. et al. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. J. Acquir. Immune Defic. Syndr. 46, 167-173 (2007). (Pubitemid 47482611)
23. Bailey, J. R. et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD41 T cells. J. Virol. 80, 6441-6457 (2006). (Pubitemid 43927447)
24. Kieffer, T. L. et al. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J. Infect. Dis. 189, 1452-1465 (2004). (Pubitemid 38543595)
25. Cu-Uvin, S. et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 24, 2489-2497 (2010).
26. North, T. W. et al. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J. Virol. 84, 2913-2922 (2010).
27. Rong, L. & Perelson, A. S. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy. PLOS Comput. Biol. 5, e1000533 (2009).
28. Grossman, Z. et al. Ongoing HIV dissemination during HAART. Nature Med. 5, 1099-1104 (1999). (Pubitemid 29474403)
29. Frenkel, L. M. et al. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J. Virol. 77, 5721-5730 (2003). (Pubitemid 36538965)
30. Rhee, S. Y. et al. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 31, 298-303 (2003).